Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

Srdan Verstovsek,1 Jason Gotlib,2 Vikas Gupta,3 Ehab Atallah,4 John Mascarenhas,5 Alfonso Quintas-Cardama,1 William Sun,6 Nicholas J Sarlis,6 Victor Sandor,6 Richard S Levy,6 Hagop M Kantarjian,1 Ruben A Mesa71University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Stanford Cancer Institu...

Full description

Bibliographic Details
Main Authors: Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA
Format: Article
Language:English
Published: Dove Medical Press 2013-12-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/management-of-cytopenias-in-patients-with-myelofibrosis-treated-with-r-a15309

Internet

http://www.dovepress.com/management-of-cytopenias-in-patients-with-myelofibrosis-treated-with-r-a15309

Similar Items